Patents by Inventor Francis A. Fitzpatrick

Francis A. Fitzpatrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Albumin stabilized prostacyclin
    Patent number: 4303671
    Abstract: The present invention provides novel formulations of prostacyclin suitable for parenteral administration and methods for making and using these formulations. These novel formulations include a pharmaceutically acceptable stabilizing concentration of albumin as a constituent thereof. Such novel formulations of prostacyclin are useful for its conventional pharmacological and therapeutical purposes, most to inhibition of blood platelet aggregation.
    Type: Grant
    Filed: July 10, 1980
    Date of Patent: December 1, 1981
    Assignee: The Upjohn Company
    Inventor: Francis A. Fitzpatrick
  • Compounds and methods
    Patent number: 4218436
    Abstract: A method for the radioimmunoassay of PGE.sub.1 -type and PGE.sub.2 -type compounds and PGX is disclosed which utilizes antibodies formed against a prostaglandin mimic.Conjugates are disclosed which are formed by attaching a prostaglandin mimic to a carrier molecule.Antibodies are disclosed which are specific against PGE.sub.1 -type and PGE.sub.2 -type compounds, PGH.sub.2, and PGX.Complexes are disclosed which are formed by binding an antibody raised against a prostaglandin mimic with its corresponding authentic prostaglandin.
    Type: Grant
    Filed: April 26, 1979
    Date of Patent: August 19, 1980
    Assignee: The Upjohn Company
    Inventor: Francis A. Fitzpatrick
  • Conjugates formed by reacting a prostaglandin mimic compound with a carrier molecule
    Patent number: 4192799
    Abstract: A method for the radioimmunoassay of PGE.sub.1 -type and PGE.sub.2 -type compounds and PGX is disclosed which utilizes antibodies formed against a prostaglandin mimic.Conjugates are disclosed which are formed by attaching a prostaglandin mimic to a carrier molecule.Antibodies are disclosed which are specific against PGE.sub.1 -type and PGE.sub.2 -type compounds, PGH.sub.2, and PGX.Complexes are disclosed which are formed by binding an antibody raised against a prostaglandin mimic with its corresponding authentic prostaglandin.
    Type: Grant
    Filed: September 21, 1977
    Date of Patent: March 11, 1980
    Assignee: The Upjohn Company
    Inventor: Francis A. Fitzpatrick